Literature DB >> 16297163

Chronic fatigue syndrome is associated with diminished intracellular perforin.

K J Maher1, N G Klimas, M A Fletcher.   

Abstract

Chronic fatigue syndrome (CFS) is an illness characterized by unexplained and prolonged fatigue that is often accompanied by abnormalities of immune, endocrine and cognitive functions. Diminished natural killer cell cytotoxicity (NKCC) is a frequently reported finding. However, the molecular basis of this defect of in vitro cytotoxicy has not been described. Perforin is a protein found within intracellular granules of NK and cytotoxic T cells and is a key factor in the lytic processes mediated by these cells. Quantitative fluorescence flow cytometry was used to the intracellular perforin content in CFS subjects and healthy controls. A significant reduction in the NK cell associated perforin levels in samples from CFS patients, compared to healthy controls, was observed. There was also an indication of a reduced perforin level within the cytotoxic T cells of CFS subjects, providing the first evidence, to our knowledge, to suggest a T cell associated cytotoxic deficit in CFS. Because perforin is important in immune surveillance and homeostasis of the immune system, its deficiency may prove to be an important factor in the pathogenesis of CFS and its analysis may prove useful as a biomarker in the study of CFS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16297163      PMCID: PMC1440524          DOI: 10.1111/j.1365-2249.2005.02935.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Quantitative fluorescence measures for determination of intracellular perforin content.

Authors:  Kevin J Maher; Nancy G Klimas; Barry Hurwitz; Richard Schiff; Mary Ann Fletcher
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.

Authors:  M Caligiuri; C Murray; D Buchwald; H Levine; P Cheney; D Peterson; A L Komaroff; J Ritz
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

3.  Homeostatic regulation of CD8+ T cells by perforin.

Authors:  D Kägi; B Odermatt; T W Mak
Journal:  Eur J Immunol       Date:  1999-10       Impact factor: 5.532

4.  Perforin gene defects in familial hemophagocytic lymphohistiocytosis.

Authors:  S E Stepp; R Dufourcq-Lagelouse; F Le Deist; S Bhawan; S Certain; P A Mathew; J I Henter; M Bennett; A Fischer; G de Saint Basile; V Kumar
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

Review 5.  The multifunctional or moonlighting protein CD26/DPPIV.

Authors:  Emil Boonacker; Cornelis J F Van Noorden
Journal:  Eur J Cell Biol       Date:  2003-02       Impact factor: 4.492

6.  Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas.

Authors:  Michele Reyes; Rosane Nisenbaum; David C Hoaglin; Elizabeth R Unger; Carol Emmons; Bonnie Randall; John A Stewart; Susan Abbey; James F Jones; Nelson Gantz; Sarah Minden; William C Reeves
Journal:  Arch Intern Med       Date:  2003-07-14

7.  High levels of type 2 cytokine-producing cells in chronic fatigue syndrome.

Authors:  A Skowera; A Cleare; D Blair; L Bevis; S C Wessely; M Peakman
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

Review 8.  Cytotoxic T lymphocytes: all roads lead to death.

Authors:  Michele Barry; R Chris Bleackley
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

9.  Decrease in CD3-negative-CD8dim(+) and Vdelta2/Vgamma9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection.

Authors:  Gabriella Pár; Daniel Rukavina; Eckhard R Podack; Margit Horányi; Júlia Szekeres-Barthó; Géza Hegedüs; Mária Paál; László Szereday; Gyula Mózsik; Alajos Pár
Journal:  J Hepatol       Date:  2002-10       Impact factor: 25.083

Review 10.  Human natural killer cells: their origin, receptors and function.

Authors:  Lorenzo Moretta; Cristina Bottino; Daniela Pende; Maria Cristina Mingari; Roberto Biassoni; Alessandro Moretta
Journal:  Eur J Immunol       Date:  2002-05       Impact factor: 5.532

View more
  55 in total

1.  A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Authors:  R Esfandyarpour; A Kashi; M Nemat-Gorgani; J Wilhelmy; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-29       Impact factor: 11.205

2.  A formal analysis of cytokine networks in chronic fatigue syndrome.

Authors:  Gordon Broderick; Jim Fuite; Andrea Kreitz; Suzanne D Vernon; Nancy Klimas; Mary Ann Fletcher
Journal:  Brain Behav Immun       Date:  2010-05-04       Impact factor: 7.217

3.  A Comparison of Immune Functionality in Viral versus Non-Viral CFS Subtypes.

Authors:  Nicole Porter; Athena Lerch; Leonard A Jason; Matthew Sorenson; Mary Ann Fletcher; Joshua Herrington
Journal:  J Behav Neurosci Res       Date:  2010-06-01

4.  Chronic Fatigue Syndrome: The Current Status and Future Potentials of Emerging Biomarkers.

Authors:  David Benjamin Fischer; Arsani Hany William; Adam Campbell Strauss; Elizabeth R Unger; Leonard Jason; Gailen D Marshall; Jordan D Dimitrakoff
Journal:  Fatigue       Date:  2014-06-01

5.  Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series.

Authors:  Øystein Fluge; Olav Mella
Journal:  BMC Neurol       Date:  2009-07-01       Impact factor: 2.474

6.  Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.

Authors:  Mary A Fletcher; Xiao R Zeng; Kevin Maher; Silvina Levis; Barry Hurwitz; Michael Antoni; Gordon Broderick; Nancy G Klimas
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

Review 7.  Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways.

Authors:  Michael Maes; Frank N M Twisk
Journal:  BMC Med       Date:  2010-06-15       Impact factor: 8.775

Review 8.  Specific correlations between muscle oxidative stress and chronic fatigue syndrome: a working hypothesis.

Authors:  Stefania Fulle; Tiziana Pietrangelo; Rosa Mancinelli; Raoul Saggini; Giorgio Fanò
Journal:  J Muscle Res Cell Motil       Date:  2008-02-15       Impact factor: 2.698

9.  Determination of quantitative and site-specific DNA methylation of perforin by pyrosequencing.

Authors:  Supraja Narasimhan; Virginia R Falkenberg; Maung M Khin; Mangalathu S Rajeevan
Journal:  BMC Res Notes       Date:  2009-06-12

10.  Immune and hemorheological changes in chronic fatigue syndrome.

Authors:  Ekua W Brenu; Donald R Staines; Oguz K Baskurt; Kevin J Ashton; Sandra B Ramos; Rhys M Christy; Sonya M Marshall-Gradisnik
Journal:  J Transl Med       Date:  2010-01-11       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.